Warner Bros. Discovery Valuation
Is WBD * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of WBD * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: WBD * (MX$166.3) is trading below our estimate of fair value (MX$458.33)
Significantly Below Fair Value: WBD * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for WBD *?
Other financial metrics that can be useful for relative valuation.
| What is WBD *'s n/a Ratio? | |
|---|---|
| n/a | 0x |
| n/a | n/a |
| Market Cap | US$20.35b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1.5x |
| Enterprise Value/EBITDA | 7.9x |
| PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does WBD *'s PS Ratio compare to its peers?
| Company | Forward PS | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2.5x | ||
CIE B Corporación Interamericana de Entretenimiento. de | 3x | n/a | Mex$14.9b |
LYV Live Nation Entertainment | 1.1x | 8.1% | US$24.9b |
FWON.K Formula One Group | 5x | 6.3% | US$18.2b |
BOL Bolloré | 1x | 8.3% | €17.5b |
WBD * Warner Bros. Discovery | 0.5x | 1.3% | Mex$20.4b |
Price-To-Sales vs Peers: WBD * is good value based on its Price-To-Sales Ratio (0.5x) compared to the peer average (2.5x).
Price to Earnings Ratio vs Industry
How does WBD *'s PE Ratio compare vs other companies in the Global Entertainment Industry?
Price-To-Sales vs Industry: WBD * is good value based on its Price-To-Sales Ratio (0.5x) compared to the Global Entertainment industry average (1.9x).
Price to Sales Ratio vs Fair Ratio
What is WBD *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PS Ratio | 0.5x |
| Fair PS Ratio | 1x |
Price-To-Sales vs Fair Ratio: WBD * is good value based on its Price-To-Sales Ratio (0.5x) compared to the estimated Fair Price-To-Sales Ratio (1x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | Mex$166.30 | Mex$205.79 +23.7% | 34.8% | Mex$427.12 | Mex$116.49 | n/a | 27 |
| Sep ’25 | Mex$150.02 | Mex$207.81 +38.5% | 35.0% | Mex$432.07 | Mex$117.84 | n/a | 27 |
| Aug ’25 | Mex$158.00 | Mex$214.72 +35.9% | 35.5% | Mex$442.62 | Mex$129.10 | n/a | 27 |
| Jul ’25 | Mex$130.62 | Mex$220.61 +68.9% | 33.5% | Mex$435.36 | Mex$126.98 | n/a | 27 |
| Jun ’25 | Mex$140.99 | Mex$209.59 +48.7% | 33.0% | Mex$403.20 | Mex$117.60 | n/a | 26 |
| May ’25 | Mex$127.02 | Mex$229.75 +80.9% | 30.2% | Mex$413.07 | Mex$120.48 | n/a | 26 |
| Apr ’25 | Mex$146.00 | Mex$228.99 +56.8% | 27.7% | Mex$400.48 | Mex$141.84 | n/a | 25 |
| Mar ’25 | Mex$147.50 | Mex$235.19 +59.5% | 29.2% | Mex$409.15 | Mex$119.34 | n/a | 24 |
| Feb ’25 | Mex$177.01 | Mex$263.94 +49.1% | 26.7% | Mex$413.01 | Mex$154.88 | n/a | 24 |
| Jan ’25 | Mex$193.02 | Mex$290.73 +50.6% | 25.4% | Mex$436.70 | Mex$157.21 | n/a | 23 |
| Dec ’24 | Mex$194.00 | Mex$282.37 +45.6% | 25.5% | Mex$429.76 | Mex$154.71 | n/a | 23 |
| Nov ’24 | Mex$180.59 | Mex$335.53 +85.8% | 22.0% | Mex$472.27 | Mex$181.64 | n/a | 25 |
| Oct ’24 | Mex$190.00 | Mex$334.70 +76.2% | 26.0% | Mex$565.16 | Mex$171.26 | n/a | 23 |
| Sep ’24 | Mex$195.00 | Mex$342.85 +75.8% | 28.2% | Mex$562.64 | Mex$170.50 | Mex$150.02 | 23 |
| Aug ’24 | Mex$217.20 | Mex$343.77 +58.3% | 29.5% | Mex$555.74 | Mex$168.41 | Mex$158.00 | 23 |
| Jul ’24 | Mex$215.40 | Mex$363.83 +68.9% | 31.0% | Mex$626.19 | Mex$173.94 | Mex$130.62 | 24 |
| Jun ’24 | Mex$199.55 | Mex$368.71 +84.8% | 30.0% | Mex$629.58 | Mex$192.37 | Mex$140.99 | 24 |
| May ’24 | Mex$247.05 | Mex$386.38 +56.4% | 30.1% | Mex$649.71 | Mex$198.52 | Mex$127.02 | 22 |
| Apr ’24 | Mex$268.79 | Mex$412.39 +53.4% | 30.0% | Mex$681.87 | Mex$208.35 | Mex$146.00 | 22 |
| Mar ’24 | Mex$271.43 | Mex$393.09 +44.8% | 31.4% | Mex$651.70 | Mex$199.13 | Mex$147.50 | 21 |
| Feb ’24 | Mex$287.00 | Mex$399.45 +39.2% | 34.0% | Mex$677.86 | Mex$169.47 | Mex$177.01 | 21 |
| Jan ’24 | Mex$180.00 | Mex$399.65 +122.0% | 35.8% | Mex$697.35 | Mex$154.97 | Mex$193.02 | 19 |
| Dec ’23 | Mex$226.50 | Mex$401.16 +77.1% | 35.2% | Mex$696.44 | Mex$154.76 | Mex$194.00 | 19 |
| Nov ’23 | Mex$264.70 | Mex$476.53 +80.0% | 43.3% | Mex$957.26 | Mex$179.49 | Mex$180.59 | 19 |
| Oct ’23 | Mex$235.01 | Mex$494.87 +110.6% | 41.4% | Mex$964.36 | Mex$180.82 | Mex$190.00 | 19 |
| Sep ’23 | Mex$258.01 | Mex$511.67 +98.3% | 41.3% | Mex$966.94 | Mex$181.30 | Mex$195.00 | 20 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.